Dr. Darren Ji will present on the Panel of “Dealmaking in China” at BioEurope 2008, November 16-19, 2008, Mannheim, Germany.
On October 27, PharmaLegacy was featured in ChinaBio Today's life science reports at: http://www.chinabiotoday.com/articles/20081027
58 Webster Jee Awards were granted to International and Chinese scientists attending ICOBR 2008. This was the largest travel awards granted in successive years to the bone researchers worldwide in the honor of Dr. Webster Jee.
PharmaLegacy leaders play a key role in International Conference of Bone and Mineral Research 2008, Beijing, China
a. Dr. Webster Jee co-chaired the scientific committee and co-organized the full scientific program at ICOBR (International Conference on Osteoporosis and Bone Research)’ 08.
b. Dr. Webster Jee, Dr. Darren Ji and Dr. Mei-Shu Shih chaired and co-chaired the scientific session at ICOBR’ 08.
c. This is the 4th time in 5 years that the leadership members of PharmaLegacy participated in key role in organizing the outing.
PharmaLegacy today announced it's Grand Opening in Shanghai, China. For full press release please see
PDF
PharmaLegacy becomes the first commercial biotech company in China adopting BioBook (IDBS), a part 11 compliant professional pharmacology data management system developed by IDBS, UK.
PharmaLegacy staff completed a second round of GLP training, conducted by Dr. Ray Takigiku, VP of QA/AC of PharmaLegacy Laboratories.
Dr. Darren Ji will present at the China panel of BioBusiness Network, to be held in Geneva from September 16-18, 2008. Dr. Ji will discuss the global picture of development opportunities of Pharmaceutical/Biotech industry in China and what China could offer to the world.
Dr. Duan continues his tenure and responsibility as one of the five Council Members of the Shanghai Experimental Animal Commission, http://www.la-res.cn/inst-list.jsp.
Dr. Darren Ji has joined the Board of Director of BayHelix for the term 2008 - 2009 http://www.bayhelix.org/board.html . BayHelix is an organization of leaders of Chinese heritage in the global life sciences and healthcare community. It aspires to shape the growth of the life sciences and healthcare industry around the Pacific Rim and beyond, foster and create business opportunities, supply and nurture the leaders for the community, and network and share information and experience.